Central Sensitization and Neuropathic Pain in Cervicogenic Headache
Prevalence of Central Sensitization and Neuropathic Pain in Patients With Cervicogenic Headache: A Case-Control Study
1 other identifier
observational
72
1 country
1
Brief Summary
Cervicogenic headache is a type of secondary headache that originates from the structures of the neck and can spread toward the head and facial regions. It is often one-sided and may be triggered by neck movement or sustained posture. The underlying mechanisms are thought to include abnormal processing of pain signals in the cervical spine and brainstem. This case-control study was designed to examine whether individuals with cervicogenic headache show higher levels of central nervous system hypersensitivity and nerve-related pain compared with healthy individuals. The study also aimed to identify how these pain mechanisms are related to sleep, mood, and functional capacity. The research was conducted at the Departments of Physical Medicine and Rehabilitation and Neurology of Yozgat Bozok University. Adults between 18 and 65 years of age who met the diagnostic criteria for cervicogenic headache were included. Age- and sex-matched healthy volunteers without chronic pain or neurological disorders were recruited as the control group. Participants completed face-to-face interviews that included sociodemographic questions and a series of validated assessment tools measuring pain characteristics, psychological state, sleep quality, and quality of life. Ethical approval was obtained from the institutional review board, and all participants provided written informed consent prior to participation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2025
CompletedFirst Submitted
Initial submission to the registry
December 5, 2025
CompletedFirst Posted
Study publicly available on registry
December 18, 2025
CompletedDecember 23, 2025
December 1, 2025
3 months
December 5, 2025
December 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Central Sensitization Inventory
Description: A 25-item self-report questionnaire that evaluates symptoms associated with central sensitization, including hypersensitivity, sleep disturbance, and emotional complaints. Scoring: Total score range 0-100. A score of 40 or higher suggests the presence of central sensitization. Turkish validation and reliability study: Conducted in 2021
At baseline
PainDETECT Questionnaire
Description: A self-administered screening tool for identifying neuropathic pain characteristics. Scoring: Total score range -1 to 38. Scores ≤12 indicate neuropathic pain is unlikely; scores ≥19 indicate neuropathic pain is likely; 13-18 indicates unclear classification. Turkish validation and reliability study: Conducted in 2013.
At baseline.
Secondary Outcomes (5)
Headache Impact Test (6 items)
At baseline
Neck Disability Index
At baseline
Hospital Anxiety and Depression Scale
At baseline
Jenkins Sleep Scale
At baseline
Short Form-36 Health Survey
At baseline
Study Arms (2)
Patient group
Age range: 18 to 65 years Diagnosis of cervicogenic headache established according to the International Classification of Headache Disorders, 3rd edition criteria Recruited from outpatient clinics of Physical Medicine and Rehabilitation and Neurology Exclusion criteria: younger than 18 or older than 65, inability to communicate, illiteracy, refusal to participate, diabetes mellitus, hypothyroidism, chronic kidney disease, malignancy, neurological diseases associated with neuropathic pain, and rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, or fibromyalgia
Healthy Control Group
Age range: 18 to 65 years No diagnosis of cervicogenic headache or chronic pain conditions Age- and sex-matched to the patient group Voluntary participation Exclusion criteria: illiteracy, refusal to participate, diabetes mellitus, hypothyroidism, chronic kidney disease, malignancy, neurological diseases associated with neuropathic pain, and rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, or fibromyalgia
Interventions
Participants in both the patient group and the healthy control group underwent a structured clinical assessment using validated instruments. The evaluation included measures of central sensitization, neuropathic pain features, headache-related disability, cervical functional impairment, psychological distress, sleep quality, and health-related quality of life. The instruments administered were the Central Sensitization Inventory, PainDETECT Questionnaire, Headache Impact Test, Neck Disability Index, Hospital Anxiety and Depression Scale, Jenkins Sleep Scale, and Short Form-36. No pharmacological or procedural intervention was applied as part of the study; the primary focus was on comparative assessment between groups.
Eligibility Criteria
The study population included 106 adult patients with cervicogenic headache and 106 age- and sex-matched healthy controls. Patients were recruited from outpatient clinics of Physical Medicine and Rehabilitation and Neurology at Bozok University, Turkey. Healthy volunteers were selected from the community and hospital staff who met the eligibility criteria.
You may qualify if:
- Adults aged 18 to 65 years
- Patient group: Clinical diagnosis of cervicogenic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria
- Healthy control group: Age- and sex-matched individuals without cervicogenic headache or other chronic pain conditions
- Adequate cognitive function and literacy to complete questionnaires
- Voluntary participation with written informed consent
You may not qualify if:
- Age younger than 18 years or older than 65 years
- Inability to communicate effectively
- Illiteracy
- Refusal to participate
- Presence of systemic diseases including diabetes mellitus, hypothyroidism, chronic kidney disease, or malignancy
- Neurological diseases associated with neuropathic pain
- Rheumatologic diseases including rheumatoid arthritis, ankylosing spondylitis, or fibromyalgia
- Withdrawal of consent or incomplete data during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yozgat Bozok University Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Yozgat, Yozgat, 66100, Turkey (Türkiye)
Related Publications (8)
Kocyigit, H., Turkish validity and reliability of short-form 36. Drug Treat, 1999. 12: p. 102-106.
BACKGROUNDDuruoz MT, Erdem D, Gencer K, Ulutatar F, Baklacioglu HS. Validity and reliability of the Turkish version of the Jenkins Sleep Scale in psoriatic arthritis. Rheumatol Int. 2018 Feb;38(2):261-265. doi: 10.1007/s00296-017-3911-2. Epub 2017 Dec 18.
PMID: 29250729BACKGROUNDDuzce Keles E, Birtane M, Ekuklu G, Kilincer C, Caliyurt O, Tastekin N, Is EE, Ketenci A, Neblett R. Validity and reliability of the Turkish version of the central sensitization inventory. Arch Rheumatol. 2021 Oct 18;36(4):518-526. doi: 10.46497/ArchRheumatol.2022.8665. eCollection 2021 Dec.
PMID: 35382371BACKGROUNDAlkan H, Ardic F, Erdogan C, Sahin F, Sarsan A, Findikoglu G. Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study. Pain Med. 2013 Dec;14(12):1933-43. doi: 10.1111/pme.12222. Epub 2013 Aug 7.
PMID: 23924395BACKGROUNDAydemir, O., Hastane anksiyete ve depresyon olcegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg., 1997. 8: p. 187-280.
BACKGROUNDTelci EA, Karaduman A, Yakut Y, Aras B, Simsek IE, Yagli N. The cultural adaptation, reliability, and validity of neck disability index in patients with neck pain: a Turkish version study. Spine (Phila Pa 1976). 2009 Jul 15;34(16):1732-5. doi: 10.1097/BRS.0b013e3181ac9055.
PMID: 19770615BACKGROUNDDikmen PY, Bozdag M, Gunes M, Kosak S, Tasdelen B, Uluduz D, Ozge A. Reliability and Validity of Turkish Version of Headache Impact Test (HIT-6) in Patients with Migraine. Noro Psikiyatr Ars. 2020 Apr 24;58(4):300-307. doi: 10.29399/npa.24956. eCollection 2021.
PMID: 34924791BACKGROUNDDemir Karakilic G, Unluel H. Prevalence of clinical sensitization phenotype and neuropathic-like pain features in patients with cervicogenic headache: a case-control study. Neurol Res. 2026 Mar;48(3):402-417. doi: 10.1080/01616412.2026.2628609. Epub 2026 Feb 14.
PMID: 41689387DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gülseren Demir Karakılıç, Assistant Professor
Yozgat Bozok University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor, Principal Investigator
Study Record Dates
First Submitted
December 5, 2025
First Posted
December 18, 2025
Study Start
July 3, 2025
Primary Completion
October 3, 2025
Study Completion
October 3, 2025
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- IPD and supporting documents will be shared upon request following the publication of the study and will be available for up to 5 years.
- Access Criteria
- De-identified IPD and supporting documents will be provided to researchers who submit a methodologically sound research proposal. Requests should be made via email to the corresponding author and, once approved, data will be shared through a secure file transfer.
Individual participant data (IPD) underlying the results reported in this study will be shared. Researchers can request access to de-identified data necessary to reproduce the study findings.